Revenue

A new study challenges the federal monopoly on deposit insurance, arguing a private, market-based model offers a more resilient future after 2023's bank failures.

As farmers face a historic squeeze, Leaf Agriculture's new funding aims to build the data plumbing for an AI revolution, turning data chaos into profit.

Jenne's partnership with Vida isn't just a deal; it's a signal. Advanced AI is leaving the enterprise lab and entering the mainstream via trusted resellers.

A groundbreaking study ranks NFL owners by their AI-rendered reputations, showing single scandals can erase decades of success, signaling a new era for PR.

Daniel Wolfe's appointment as Editor-in-Chief signals a major pivot for Digital Insurance, doubling down on AI as a definitive growth signal for the industry.

A major financial outlook warns that geopolitical fragmentation, stubborn inflation, and a new AI arms race are creating a new reality for investors.

Beacon Biosignals is merging AI-driven brain monitoring with home sleep testing, creating a powerful new platform that could redefine neurological diagnostics.

A seismic shift is underway in the beauty industry. The era of sprawling global supply chains is giving way to a new, agile model of local-first production.

Futuri launches TopLine Enterprise, promising massive ROI by automating sales admin. We analyze if its data-centric approach can cut through a crowded AI market.

A new partnership brings enterprise-grade governance to AI-generated code, aiming to solve the growing security blind spot in automated software development.

MAIA Biotechnology isn't just opening a new trial site; it's accelerating its assault on a $70B market with a drug showing remarkable early results.

SEALSQ's CEO leads a crucial quantum semiconductor talk in Munich, highlighting the race to scale quantum tech and the urgent need for post-quantum security.

Swedish freight-tech leader Einride's explosive Nasdaq debut validates a ten-year mission to build the resilient, autonomous future of supply chains.

A landmark bill aims to end U.S. reliance on foreign magnets by incentivizing domestic production, including innovative rare-earth-free alternatives.

A new Florida venture embeds sleep apnea treatment into cardiology care, a model that could reshape patient outcomes and Vivos Therapeutics' market strategy.

Komodor's new AI platform moves beyond reactive fixes, proactively preventing the structural inefficiencies that strand up to 30% of Kubernetes capacity.

A market set to triple, driven by gene-level therapies, promises a revolution for children with rare epilepsies. But can our systems deliver this hope?

With its 'Dark Arisen' expansion, Capcom is not just adding to Dragon's Dogma 2. It's executing a shrewd plan to fix past mistakes and conquer new markets.

Lavazza doubles down on the Montréal Jazz Fest, but this isn't just about coffee. It's a calculated move to conquer Québec's market. Here's the strategy.

BFGoodrich's new Trail-Terrain T/A+ isn't just for off-road trails. It's a calculated move into the EV market and a bid to win the everyday adventurer.